Therapeutic gases for neonatal and pediatric respiratory care

Respiratory Care

Volumn 48, Issue 4, 2003, Pages 399-422

  Myers, Timothy R ^a,b  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

Airway obstruction; Asthma; Bronchiolitis; Carbon dioxide; Croup; Heliox; Hypoplastic left heart; Hypoxic gas; Neonatal; Nitric oxide; Pediatric; Pulmonary; Respiratory; Respiratory failure; Stridor

Indexed keywords

ADRENALIN; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CARBON DIOXIDE; CORTICOSTEROID; DEXAMETHASONE; GLYCERYL TRINITRATE; HELIOX; METHYLPREDNISOLONE; NITRIC OXIDE; NITROGEN; NITROPRUSSIDE SODIUM; OXYGEN; PLACEBO; PROSTACYCLIN; PROSTAGLANDIN; PROSTAGLANDIN E1; SALBUTAMOL; SURFACTANT; HELIUM; VASODILATOR AGENT;

AIR; AIRWAY OBSTRUCTION; AIRWAY PRESSURE; AIRWAY RESISTANCE; ANALYZER; ARTERIAL CARBON DIOXIDE TENSION; ARTIFICIAL VENTILATION; ASTHMA; BLOOD OXYGEN TENSION; BREATHING; BRONCHIOLITIS; CHRONIC LUNG DISEASE; CLINICAL TRIAL; COMPARATIVE STUDY; CONFERENCE PAPER; CONGENITAL DIAPHRAGM HERNIA; CONTINUOUS INFUSION; CROUP; DENSITY; DRUG DOSE REDUCTION; EXTRACORPOREAL OXYGENATION; EXTUBATION; GAS; GAS MIXING; HEART SURGERY; HELIUM OXYGEN BREATHING; HEMODYNAMICS; HIGH FREQUENCY VENTILATION; HUMAN; HYPERVENTILATION; HYPOPLASTIC LEFT HEART SYNDROME; HYPOXIA; INFANCY; INHALATION; INTERMITTENT MANDATORY VENTILATION; LUNG BLOOD FLOW; LUNG VASCULAR RESISTANCE; LUNG VENTILATION; NEBULIZATION; NEONATAL RESPIRATORY DISTRESS SYNDROME; NEWBORN; NEWBORN PERIOD; OXYGENATION; PEDIATRICS; PHYSICS; PREMATURITY; PREOPERATIVE CARE; PULMONARY HYPERTENSION; RESPIRATORY CARE; RESPIRATORY DISTRESS; RESPIRATORY FAILURE; STRIDOR; SYSTEMIC VASCULAR RESISTANCE; TISSUE PERFUSION; TURBULENT FLOW; VASOCONSTRICTION; VASODILATATION; VENTILATOR; ANOXIA; CHILD; INFANT; INHALATIONAL DRUG ADMINISTRATION; PATHOPHYSIOLOGY; REVIEW;

ADMINISTRATION, INHALATION; AIRWAY OBSTRUCTION; ANOXIA; CARBON DIOXIDE; CHILD; CLINICAL TRIALS; GASES; HELIUM; HUMANS; INFANT; INFANT, NEWBORN; NITRIC OXIDE; OXYGEN; RESPIRATORY THERAPY; VASODILATOR AGENTS;

EID: 0037997309     PISSN: 00201324     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (102)

1. Barach A. The use of helium in the treatment of asthma and obstructive lesions in the larynx and trachea. Ann Intern Med 1935;9:739-765.
2. Jolliet P, Tassaux D. Helium-oxygen ventilation. Respir Care Clin N Am 2002;8(2):295-307.
3. Carter ER, Webb CR, Moffitt DR. Evaluation of heliox in children hospitalized with acute severe asthma: a randomized crossover trial. Chest 1996;109(5):1256-1261.
4. Kudukis TM, Manthous CA, Schmidt GA, Hall JB, Wylam ME. Inhaled helium-oxygen revisited: effect of inhaled helium-oxygen during the treatment of status asthmaticus in children. J Pediatr 1997;130(2):217-224.
5. Kemper KJ, Ritz RH, Benson MS, Bishop MS. Helium-oxygen mixture in the treatment of postextubation stridor in pediatric trauma patients. Crit Care Med 1991;19(3):356-359.
6. Rodeberg DA, Easter AJ, Washam MA, Housinger TA, Greenhalgh DG, Warden GD. Use of a helium-oxygen mixture in the treatment of postextubation stridor in pediatric patients with burns. J Burn Care Rehabil 1995;16(5):476-480.
7. Connolly KM, McGuirt WF Jr. Avoiding intubation in the injured subglottis: the role of heliox therapy. Ann Otol Rhinol Laryngol 2001;110(8):713-717.
8. Grosz AH, Jacobs IN, Cho C, Schears GJ. Use of helium-oxygen mixtures to relieve upper airway obstruction in a pediatric population. Laryngoscope 2001;111(9):1512-1514.
9. Duncan PG. Efficacy of helium-oxygen mixtures in the management of severe viral and post-intubation croup. Can Anaesth Soc J 1979;26(3):206-212.
10. Nelson DS, McClellan L. Helium-oxygen mixtures as adjunctive support for refractory viral croup. Ohio State Med J 1982;78(10):729-730.
11. Terregino CA, Nairn SJ, Chansky ME, Kass JE. The effect of heliox on croup: a pilot study. Acad Emerg Med 1998;5(11):1130-1133.
12. Weber JE, Chudnofsky CR, Younger JG, et al. A randomized comparison of helium-oxygen mixtures (Heliox) and racemic epinephrine for the treatment of moderate to severe croup. Pediatrics 2001;107(6):E96.
13. Martinon-Torres F, Rodriguez-Nunez A, Martinon-Sanchez JM. Heliox therapy in infants with acute bronchiolitis. Pediatrics 2002;109(1):68-73.
14. Hollman G, Shen G, Zeng L, Yngsdal-Krenz R, Perloff W, Zimmerman J, Strauss R. Helium-oxygen improves Clinical Asthma Scores in children with acute bronchiolitis. Crit Care Med 1998;26(10):1731-1736.
15. Gross MF, Spear RM, Peterson BM. Helium-oxygen mixture does not improve gas exchange in mechanically ventilated children with bronchiolitis. Crit Care 2000;4(3):188-192.
16. Stillwell PC, Quick JD, Munro PR, Mallory GB Jr. Effectiveness of open-circuit and oxyhood delivery of helium-oxygen. Chest 1989;95(6):1222-1224.
17. Jaber S, Fodil R, Carlucci A, Boussarsar M, Pigeot J, Lemaire F, et al. Noninvasive ventilation with helium-oxygen in acute exacerbations of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2000;161(4 Pt 1):1191-1200.
18. Jolliet P, Tassaux D, Thouret JM, Chevrolet JC. Beneficial effects of helium:oxygen versus air:oxygen noninvasive pressure support in patients with decompensated chronic obstructive pulmonary disease. Crit Care Med 1999;27(11):2422-2429.
19. Devabhaktuni VG, Torres A Jr, Wilson S, Yeh MP. Effect of nitric oxide, perfluorocarbon, and heliox on minute volume measurement and ventilator volumes delivered. Crit Care Med 1999;27(8):1603-1607.
20. Tassaux D, Jolliet P, Thouret JM, Roeseler J, Dorne R, Chevrolet JC. Calibration of seven ICU ventilators for mechanical ventilation with helium-oxygen mixtures Am J Respir Crit Care Med 1999;160(1):22-32.
21. Palmer RMJ, Ferrige AG, Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 1987;327(6122):524-526.
22. Ignarro LJ. Biological actions and properties of endothelium-derived nitric oxide formed and released from artery and vein. Circ Res 1989;65(1):1-21.
23. Hurford WE. The biologic basis for inhaled nitric oxide. Respir Care Clin N Am 1997;3(3):357-369.
24. Frostell CG, Blomqvist H, Hedenstierna G, Lundberg J, Zapol WM. Inhaled nitric oxide selectively reverses human hypoxic pulmonary vasoconstriction without causing systemic vasodilation. Anesthesiology 1993;78(3):427-435.
25. Frostell C, Fratacci MD, Wain JC, Jones R, Zapol WM. Inhaled nitric oxide: a selective pulmonary vasodilator reversing hypoxic pulmonary vasoconstriction. Circulation 1991;83(6):2038-2047.
26. Chiodi H, Mohler JG. Effects of exposure of blood hemoglobin to nitric oxide. Environ Res 1985;37(2):355-363.
27. Gaston B, Drazen JM, Loscalzo J, Stamler JS. The biology of nitrogen oxides in the airways. Am J Respir Crit Care Med 1994;149(2 Pt 1):538-551.
28. Guidotti T. The higher oxides of nitrogen. Inhalation toxicology. Environ Res 1978;15(3):443-472.
29. Hurford WE. Inhaled nitric oxide. Respir Care Clin N Am 2002;8(2):261-279.
30. The Neonatal Inhaled Nitric Oxide Study Group (NINOS). Inhaled nitric oxide in full-term and nearly full-term infants with hypoxic respiratory failure. N Engl J Med 1997;336(9):597-604.
31. Clark RH, Kueser TJ, Walker MW, Southgate WM, Huckaby JL, Perez JA, et al (Clinical Inhaled Nitric Oxide Research Group). Low-dose nitric oxide therapy for persistent pulmonary hypertension of the newborn. N Engl J Med 2000;342(7):469-474.
32. Davidson D, Barefield ES, Kattwinkel J, Dudell G, Damask M, Straube R, et al. Inhaled nitric oxide for the early treatment of persistent pulmonary hypertension of the term newborn: a randomized, doublemasked, placebo-controlled, dose-response, multicenter study. The INO/PPHN Study Group. Pediatrics 1998;101(3 pt 1):325-334.
33. Hoffman GM, Ross GA, Day SE, Rice TB, Nelin D. Inhaled nitric oxide reduces the utilization of extracorporeal membrane oxygenation in persistent pulmonary hypertension of the newborn. Crit Care Med 1997;25(2):352-359.
34. Wood KS, McCaffrey MJ, Donovan JC, Stiles AD, Bose CL. Effect of initial nitric oxide concentration on outcome in infants with persistent pulmonary hypertension of the newborn. Biol Neonate 1999;75(4):215-224.
35. Lonnqvist PA. Efficacy and economy of inhaled nitric oxide in neonates accepted for extra-corporeal membrane oxygenation. Acta Physiol Scand 1999;167(2):175-179.
36. Mercier JC, Lacaze T, Storme L, Roze JC, Dinh-Xuan AT, Dehan M. Disease-related response to inhaled nitric oxide in newborns with severe hypoxaemic respiratory failure. French Paediatric Study Group of Inhaled NO. Eur J Pediatr 1998;157(9):747-752.
37. Roberts JD Jr, Fineman JR, Morin FC 3rd, Shaul PW, Rimar S, Schreiber MD, et al. Inhaled nitric oxide and persistent pulmonary hypertension of the newborn. The Inhaled Nitric Oxide Study Group. N Engl J Med 1997;336(9):605-610.
38. Finer NN, Barrington KJ. Nitric oxide for respiratory failure in infants born at or near term (Cochrane Review). In: The Cochrane Library, Issue 1 2003. Oxford: Update Software.
39. Kachel W, Varnholt V, Lasch P, Muller W, Lorenz C, Wirth H. High-frequency oscillatory ventilation and nitric oxide: alternative or complementary to ECMO. Int J Artif Organs 1995;18(10):589-597.
40. Kennaugh JM, Kinsella JP, Abman SH, Hernandez JA, Moreland SG, Rosenberg AA. Impact of new treatments for neonatal pulmonary hypertension on extracorporeal membrane oxygenation use and outcome. J Perinatol 1997;17(5):366-369.
41. Kinsella JP, Truog WE, Walsh WF, Goldberg RN, Bancalari E, Mayock DE, et al. Randomized, multicenter trial of inhaled nitric oxide and high-frequency oscillatory ventilation in severe, persistent pulmonary hypertension of the newborn. J Pediatr 1997;131(1 Pt 1):55-62.
42. Metkus AP, Esserman L, Sola A, Harrison MR, Adzick NS. Cost per anomaly: what does a diaphragmatic hernia cost? J Pediatr Surg 1995;30(2):226-230.
43. Leveque C, Hamza J, Berg AE, Barbotin-Larrieu F, Laguenie G, Goutail-Flaud F, et al. Successful repair of a severe left congenital diaphragmatic hernia during continuous inhalation of nitric oxide. Anesthesiology 1994;80(5):1171-1175.
44. Karamanoukian HL, Glick PL, Zayek M, Steinhorn RH, Zwass MS, Fineman JR, Morin FC 3rd. Inhaled nitric oxide in congenital hypoplasia of the lungs due to diaphragmatic hernia or ogliohydramnios. Pediatrics 1994;94(5):715-718.
45. Shah N, Jacob T, Exler R, Morrow S, Ford H, Albanese C, et al. Inhaled nitric oxide in congenital diaphragmatic hernia. J Pediatr Surg 1994;29(8):1010-1014; discussion 1014-1015.
46. Frostell CG, Lonnqvist PA, Sonesson SE, Gustafsson LE, Lohr G, Noack G. Near fatal pulmonary hypertension after surgical repair of congenital diaphragmatic hernia: successful use of inhaled nitric oxide. Anesthesia 1993;48(8):679-683.
47. Neonatal Inhaled Nitric Oxide Study Group (NINOS). Inhaled nitric oxide and hypoxic respiratory failure in infants with congenital diaphragmatic hernia. Pediatrics 1997;99(6):838-845.
48. Beckman JS, Beckman TW, Chen J, Marshall PA, Freeman BA. Apparent hydroxy radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci U S A 1990;87(4):1620-1624.
49. Issa A, Lappalainen U, Kleinman M, Bry K, Hallman M. Inhaled nitric oxide decreases heperoxia-induced surfactant abnormality in preterm rabbits. Pediatr Res 1999;45(2):247-254.
50. Banks BA, Seri I, Ischiropoulos H, Merrill J, Rychik J, Ballard RA. Changes in oxygenation with inhaled nitric oxide in severe bronchopulmonary dysplasia. Pediatrics 1999;103(3):610-618.
51. Longnqvist PA, Jonsson B, Winberg P, Frostell CG. Inhaled nitric oxide in infants with developing or established chronic lung disease. Acta Paediatr 1995;84(10):1188-1192.
52. Thompson MW, Bates JN, Klein JM. Treatment of respiratory failure in an infant with bronchopulmonary dysplasia infected with respiratory syncytial virus using inhaled nitric oxide and high frequency ventilation. Acta Paediatr 1995;84(1):100-102.
53. Abman SH, Griebel JL, Parker DK, Schmidt JM, Swanton D, Kinsella JP. Acute effects of inhaled nitric oxide in children with severe hypoxemic respiratory failure. J Pediatr 1994;124(6):881-888.
54. Hoehn T, Krause M, Krueger M, Hentschel R. Treatment of respiratory failure with inhaled nitric oxide and high-frequency ventilation in an infant with respiratory syncytial virus pneumonia and bronchopulmonary dysplasia. Respiration 1998;65(6):477-480.
55. Peliowski A, Finer NN, Etches PC, Tierney AJ, Ryan CA. Inhaled nitric oxide for premature infants after prolonged rupture of the membranes. J Pediatr 1995;126(3):450-453.
56. Abman SH, Kinsella JP, Schaffer MS, Wilkening RB. Inhaled nitric oxide in the management of a premature newborn with severe respiratory distress and pulmonary hypertension. Pediatrics 1993;92(4):606-609.
57. Cheung PY, Peliowski AP, Robertson CM. The outcome of very low birth weight neonates (≤ 1500 g) rescued by inhaled nitric oxide: neurodevelopment in early childhood. J Pediatr 1998;133(6):735-739.
58. Skimming JW, Bender KA, Hutchison AA, Drummond WH. Nitric oxide inhalation in infants with respiratory distress syndrome. J Pediatr 1997;130(2):225-230.
59. Kinsella JP, Walsh WF, Bose CL, Gerstmann DR, Labella JJ, Sardesai S, et al. Inhaled nitric oxide in premature neonates with severe hypoxaemic respiratory failure: a randomised contolled trial. Lancet 1999;354(9184):1061- 1065.
60. Subhedar NV, Ryan SW, Shaw NJ. Open randomised trial of inhaled nitric oxide and early dexamethasone in high risk preterm infants. Arch Dis Child Fetal Neonatal Ed 1997;77(3):F185-F190.
61. The Franco-Belgium Collaborative NO Trial Group. Early compared with delayed inhaled nitric oxide in moderately hypoxaemic neonates with respiratory failure: a randomised controlled trial. Lancet 1999;354(9184):1066-1071.
62. Ashbaugh DG, Bigelow DB, Petty TL, Levine BE. Acute respiratory distress in adults. Lancet 1967;2(7571):319-323.
63. Timmons OD, Havens PL, Fackler JC. Predicting death in pediatric patients with acute respiratory failure. Pediatric Critical Care Study Group. Extracorporeal Life Support Organization. Chest 1995;108(3):789-797.
64. Day RW, Allen EM, Witte MK. A randomized, controlled study of the 1-hour and 24-hour effects of inhaled nitric oxide therapy in children with acute hypoxemic respiratory failure. Chest 1997;112(5):1324-1331.
65. Day RW, Guarin M, Lynch JM, Vernon DD, Dean JM. Inhaled nitric oxide in children with severe lung disease: results of acute and prolonged therapy with two concentrations. Crit Care Med 1996;24(2):215-221.
66. Demirakca S, Dotsch J, Knothe C, Magsaam J, Reiter HL, Bauer J, Kuehl PG. Inhaled nitric oxide in neonatal and pediatric acute respiratory distress syndrome: dose response, prolonged inhalation and weaning. Crit Care Med 1996;24(11):1913-1919.
67. Nakagawa TA, Morris A, Gomez RJ, Johnston SJ, Sharkey PT, Zaritsky AL. Dose response to inhaled nitric oxide in pediatric patients with pulmonary hypertension and acute respiratory distress syndrome. J Pediatr 1997;131(1 Pt 1):63-69.
68. Sheridan RL, Zapol WM, Ritz RH, Tompkins RG. Low-dose inhaled nitric oxide in acutely burned children with profound respiratory failure. Surgery 1999;126(5):856-862.
69. Okamoto K, Hamaguchi M, Kukita I, Kikuta K, Sato T. Efficacy of inhaled nitric oxide in children with ARDS. Chest 1998;114(3):827-833.
70. Goldman AP, Tasker RC, Hosiasson S, Henrichsen T, Macrae DJ. Early response to inhaled nitric oxide and its relationship to outcome in children with severe hypoxemic respiratory failure. Chest 1997;112(3):752-758.
71. Whitaker K. Comprehensive perinatal & pediatric respiratory care, 2nd ed. Albany: Delmar Publishers; 1997.
72. Miller OI, Celermajer DS, Deanfield JE, Macrae DJ. Very-low-dose inhaled nitric oxide: a selective pulmonary vasodilator after operations for congenital heart disease. J Thorac Cardiovasc Surg 1994;108(3):487-494.
73. Journois D, Pouard P, Mauriat P, Malhere T, Vouhe P, Safran D. Inhaled nitric oxide as a therapy for pulmonary hypertension after operations for congenitap heart defects. J Thorac Cardiovasc Surg 1994;107(4):1129-1135.
74. Curran RD, Mavroudis C, Backer CL, Sautel M, Zales VR, Wessel DL. Inhaled nitric oxide for children with congenital heart disease and pulmonary hypertension. Ann Thorac Surg 1995;60(6):1765-1771.
75. Russell IA, Zwass MS, Fineman JR, Balea M, Rouine-Rapp K, Brook M, et al. The effects of inhaled nitric oxide on postoperative pulmonary hypertension in infants and children undergoing surgical repair of congenital heart disease. Anesth Analg 1998;87(1):46-51.
76. Day RW, Hawkins JA, McGough EC, Crezee KL, Orsmond GS. Randomized controlled study of inhaled nitric oxide after operation for congenital heart disease. Ann Thorac Surg 2000;69(6):1907-1912; discussion 1913.
77. Morris K, Beghetti M, Petros A, Adatia I, Bohn D. Comparison of hyperventilation and inhaled nitric oxide for pulmonary hypertension after repair of congenital heart disease. Crit Care Med 2000;28(8):2974-2978.
78. Miller OI, Tang SF, Keech A, Pigott NB, Beller E, Celermajer DS. Inhaled nitric oxide and prevention of pulmonary hypertension after congenital heart surgery: a randomised double-blind study. Lancet 2000;356(9240):1464-1469.
79. Goldman AP, Delius RE, Deanfield JE, Macrae DJ. Nitric oxide is superior to prostacyclin for pulmonary hypertension after cardiac operations. Ann Thorac Surg 1995;60(2):300-305; discussion 306.
80. INO Therapeutics Inc. Package literature for INOmax. 13 Aug 1999.
81. Wessel DL, Adatia I, Thompson JE, Hickey PR. Delivery and monitoring of inhaled nitric oxide in patients with pulmonary hypertension. Crit Care Med 1994;22(6):930-938.
82. Snell GI, Salamonsen RF, Bergin P, Esmore DS, Khan S, Williams TJ. Inhaled nitric oxide used as a bridge to heart-lung transplantation in a patient with end-stage pulmonary hypertension. Am J Respir Crit Care Med 1995;151(4):1263-1266.
83. Yoshida M, Taguchi O, Gabazza EC, Kobayashi T, Yamakami T, Kobayashi H, et al. Combined inhalation of nitric oxide and oxygen in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1997;155(2):526-529.
84. Channick RN, Newhart JW, Johnson FW, Williams PJ, Auger WR, Fedullo PF, Moser KM. Pulsed delivery of inhaled nitric oxide to patients with primary pulmonary hypertension: an ambulatory delivery system and initial clinical tests. Chest 1996;109(6):1545-1549.
85. Tracy M, Myers T, Chatburn R. Evaluation of oxyhoods for the delivery of nitric oxide (abstract). Respir Care 1999;44(10):1272.
86. El-Lessy HN. Pulmonary vascular control in hypoplastic left-heart syndrome: hypoxic and hypercarbic-gas therapy. Respir Care 1995;40(7):737-742.
87. Castaneda A, Jonas R, Mayer J, et al. Cardiac surgery of the neonate and infant. Philadelphia: WB Saunders; 1994.
88. Jonas RA, Hansen DD, Cook N, Wessel D. Anatomic subtype and survival after reconstructive operation for hypoplastic left heart syndrome. J Thorac Cardiovasc Surg 1994;107(4):1121-1127; discussion 1127-1128.
89. Turner DR, Forbes TJ. Hypoplastic left heart syndrome. EMedicine Journal May 2001;2(5). Available at http://www.emedicine.com/ped/topic1131.htm (accessed 2/14/03).
90. Barnea O, Austin EH, Richman B, Santamore WP. Balancing the circulation: theoretic optimization of pulmonary/systemic flow ratio in hypoplastic left heart syndrome. J Am Coll Cardiol 1994;24(5):1376-1381.
91. Austin EH, Santamore WP, Barnea O. Balancing the circulation in hypoplastic left heart syndrome. J Cardiovasc Surg (Torino) 1994;35(6 Suppl 1):137-139.
92. Riordan CJ, Randsbeck F, Storey JH, Montgomery WD, Santamore WP, Austin EH 3rd. Effects of oxygen, positive end-expiratory pressure, and carbon dioxide on oxygen delivery in an animal model of the univentricular heart. J Thorac Cardiovasc Surg 1996;112(3):644-654.
93. Jobes DR, Nicolson SC, Steven JM, Miller M, Jacobs ML, Norwood WI Jr. Carbon dioxide prevents pulmonary overcirculation in hypoplastic left heart syndrome. Ann Thorac Surg 1992;54(1):150-151.
94. Morray JP, Lynn AM, Mansfield PB. Effect of pH and PCO2 on pulmonary and systemic hemodynamics after surgery in children with congenital heart disease and pulmonary hypertension. J Pediatr 1988;113(3):474-479.
95. Mora GA, Pizarro C, Jacobs ML, Norwood WI. Experimental model of single ventricle. Influence of carbon dioxide on pulmonary vascular dynamics. Circulation 1994;90(5 Pt 2):II43-II46.
96. Hoffman MF, Fergus LC, McLeary TP. Controlling arterial carbon dioxide tensions with carbon dioxide gas during mechanical ventilation. Respir Care 1976;21(7):603-609.
97. Chatburn RL, Anderson SM. Controlling carbon dioxide delivery during mechanical ventilation. Respir Care 1994;39(11):1039-1046.
98. Day RW, Tani LY, Minich LL, Shaddy RE, Orsmond GS, Hawkins JA, McGough EC. Congenital heart disease with ductal-dependent systemic perfusion: Doppler ultrasonography flow velocities are altered by changes in the fraction of inspired oxygen. J Heart Lung Transplant 1995;14(4):718-725.
99. Day RW, Barton AJ, Pysher TJ, Shaddy RE. Pulmonary vascular resistance of children treated with nitrogen during early infancy. Ann Thorac Surg 1998;65(5):1400-1404.
100. Myers TR, Chatburn RL. Accuracy of oxygen analyzers at subatmospheric concentrations used in treatment of hypoplastic left heart syndrome. Respir Care 2002;47(10):1168-1172.
101. Dolcini DM, Smith PC, Myers TR, Chatburn RL. Delivery of sub-atmospheric oxygen concentrations during mechanical ventilation of children with heart disease (abstract). Respir Care 2000;45(8):1009.
102. Dolcini DM, Myers TR, Chatburn RL. Comparison of two methods to deliver subambient oxygen to infants with hypoplastic left hearts via an oxyhood (abstract). Respir Care 2001;46(10):1116.